
The FDA today approved the first 3-month, long-acting atypical antipsychotic to treat schizophrenia.

The FDA today approved the first 3-month, long-acting atypical antipsychotic to treat schizophrenia.

Consultant pharmacists review patient drug regimens, audit, and administer medications.

Many consultant pharmacists are taking on new roles and responsibilities in the shifting long-term care landscape, allowing them to perform a number of enhanced services.

The largest and most recent analysis of digoxin has reaffirmed the drug's association with a heightened risk of early death in patients with atrial fibrillation (AF) or congestive heart failure (CHF).

Asthma controller medications are underused in neighborhoods with high rates of asthma-related emergency room use and hospitalization, but pharmacists are in a prime position to correct it.

Although metformin can help prevent diabetes onset in those at high risk, the medication is rarely prescribed for this purpose.

The FDA today expanded the indication of fluticasone furoate/vilanterol (Breo Ellipta) for the treatment of asthma.

The FDA today cleared a first-of-its-kind pregnancy test that can determine a woman's pregnancy status by analyzing her blood.

As the international community struggles to provide aid and resources to Nepal following Saturday's devastating earthquake, a commission has shed light on the consequences of inadequate or inaccessible critical care around the globe.

Long-term exposure to air pollution may damage brain structures and impair cognitive function in middle-aged and older adults.

While many parents remain concerned that the measles-mumps-rubella (MMR) vaccine could cause their children to develop autism, a study has reaffirmed there is no link between the vaccine's use and increased autism risk.

Pharmacists in New Jersey now have a new tool to use in their efforts to prevent drug diversion and abuse, thanks to a mobile app recently launched by the state's Division of Consumer Affairs.

During her studies at the University at Buffalo (UB) School of Pharmacy and Pharmaceutical Sciences, Madeline Waldron has demonstrated a natural aptitude toward leadership.

The FDA today expanded the indication of Allergan's onabotulinumtoxinA (Botox), allowing the drug to be used for the treatment of upper limb spasticity in adults.

In addition to relieving pain, acetaminophen may cause patients to experience less intense emotional responses.

The FDA is warning pharmacists that pets are at risk of death when exposed to topical pain medications containing flurbiprofen.

New drug is the first approved generic of Copaxone.

The FDA today approved Sandoz's glatiramer acetate (Glatopa), a once-daily injection indicated for relapsing forms of multiple sclerosis.

FDA warns of potential issues from diabetes drugs Onglyza, Kombiglyze, and Nesina.

The recent outbreak of a drug-resistant strain of shigellosis is giving pharmacists an important role in preventing and treating the gastrointestinal disease.

An FDA advisory panel recommends adding a warning about the potential risk for heart failure to the labels of saxagliptin (Onglyza), saxagliptin/metformin (Kombiglyze), and alogliptin (Nesina).

Even though kids with neurological disorders are at high risk for flu-related complications, they are no more likely to receive annual flu vaccination than healthy children.

With prescription drug prices rising above reimbursement rates, many pharmacists are seeing patients struggle to access generic drugs.

Lack of information sharing in care transitions can lead to adverse outcomes.

Although depression is increasingly prevalent in children and teenagers, the most commonly prescribed antidepressants afford limited therapeutic benefit to kids.

While effective coordination during a patient's transition from hospital to home can improve outcomes, the process is frequently hindered by poor communication between hospital clinicians and primary care providers.

A number of sterility concerns have prompted the FDA and the North Carolina Board of Pharmacy to warn health care providers, veterinarians, and patients not to use products made and distributed by the Prescription Center pharmacy in Fayetteville.

Although glyburide is commonly prescribed for gestational diabetes mellitus, the drug's use among pregnant women may put newborns at greater risk for complications.

Responding to the growing number of deaths related to prescription opioid overdose, the US Department of Health and Human Services recently announced new opioid abuse countermeasures.

The FDA today approved Teva's albuterol sulfate inhalation powder (Proair RespiClick).